key developments in non-metastatic & metastatic hormone-sensitive prostate cancer
Published 6 years ago • 110 plays • Length 22:36Download video MP4
Download video MP3
Similar videos
-
25:53
developments in metastatic hormone-sensitive prostate cancer
-
28:26
key developments in prostate cancer
-
18:54
asco 2018: latest developments in non-metastatic & metastatic castration-resistant prostate cancer
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
6:53
perspectives on metastatic hormone-sensitive prostate cancer | bayer
-
1:22
advances in non-metastatic castration-resistant prostate cancer
-
18:01
clinical updates for metastatic hormone sensitive prostate cancer at asco 2019
-
1:32
dr. bradley on next steps for research in nonmetastatic prostate cancer
-
5:49
adt plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: systemic review
-
26:35
esmo 2021: updates in hormone-sensitive prostate cancer
-
5:06
psmaddition: 177lu-psma-617 plus soc vs. soc alone in metastatic hormone-sensitive prostate cancer
-
6:41
esmo expert report on combination therapy in advanced prostate cancer @ asco gu 2022
-
15:46
updates in metastatic prostate cancer
-
1:01:45
metastatic hormone sensitive prostate cancer: expert guidance for urologists
-
1:26
dr. burgess on key data in metastatic castration-sensitive prostate cancer
-
2:12
abiraterone for metastatic, hormone sensitive, prostate cancer
-
23:29
auau podcast: treatment for metastatic hormone sensitive prostate cancer
-
4:52
docetaxel in non-metastatic prostate cancer
-
4:01
effect of darolutamide in metastatic, hormone-sensitive prostate cancer